Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
IPH.PAthis companyInnate Pharma S.A.	€1.31	-2.91×	-6.59×	51.33×	-2.46×	-112.1%	100.0%	-2058.0%	-1764.5%	226.6%	-146.1%	-37.0%	-1.04×	0.1×	-18.38×	1.27×	0.0%	3	-22.95	2	C
ABNX.PAABIONYX Pharma S.A.	€1.59	-23.69×	31.58×	33.12×	-23.64×	-400.0%	9.3%	-154.0%	-136.6%	-130.3%	-65.5%	-2.4%	0.89×	-0.05×	-31.28×	1.06×	0.0%	2	2.27	1	D+
ADOC.PAAdocia S.A.	€2.98	-7.88×	88.12×	89.07×	-8.01×	-141.8%	-1214.0%	-1229.6%	-1124.8%	-1112.7%	-142.9%	-5.2%	5.97×	0.54×	-25.12×	1.19×	0.0%	2	-1.29	2	C
ALCJ.PACrossject S.A.	€1.25	-10.95×	-23.48×	0×	-17.93×	-116.2%	0.0%	0.0%	0.0%	212.7%	-39.8%	-9.5%	-4.07×	-2.05×	-7.67×	2.35×	0.0%	3	0.54	1	D+
ALCLS.PACellectis S.A.	€1.05	-7.05×	6.52×	6.52×	-24.8×	-443.6%	72.5%	-55.3%	-92.7%	-92.7%	-19.9%	-8.9%	1.2×	-1.38×	-4.98×	1.62×	0.0%	2	-1.71	1	D+
ALMDT.PAMedian Technologies S.A.	€3.62	-5.1×	-4.95×	7.45×	-7.06×	-184.5%	103.0%	-68.2%	-145.8%	96.9%	186.6%	-10.4%	-0.62×	-0.14×	-0.9×	0.67×	0.0%	2	0.73	2	C
Peer median	—	-7.88×	6.52×	7.45×	-17.93×	-184.5%	9.3%	-68.2%	-136.6%	-92.7%	-39.8%	-8.9%	0.89×	-0.14×	-7.67×	1.19×	0.0%	2	0.54	1	—